no code implementations • 26 Jul 2022 • Aldo Pacchiano, Drausin Wulsin, Robert A. Barton, Luis Voloch
The problem of how to genetically modify cells in order to maximize a certain cellular phenotype has taken center stage in drug development over the last few years (with, for example, genetically edited CAR-T, CAR-NK, and CAR-NKT cells entering cancer clinical trials).
